Skip to content
Agentic OS
Menu

Intelligence / Healthtech / FDA 510(k) Clearances / Berkeley Advanced Biomaterials

Approvalsdevice cleared27 Aug 2026

Berkeley Advanced Biomaterials

27 Aug 2026: Device cleared · Accelagen Plus Surgical Matrix, 1cc (CG-01AP);Accelagen Plus Surgical Matrix, 3cc (CG-03AP);Accelagen Plus Surgical Matrix, 5cc (CG-05AP);Accelagen Plus Surgical Strip, 125x25x2mm (CG-125X25AP);Accelagen Plus Surgical Strip, 250x25x2mm (CG-250X25AP). Recorded in the openFDA device 510(k) data.

View the source record

Decided
27 Aug 2026
Device
Accelagen Plus Surgical Matrix, 1cc (CG-01AP);Accelagen Plus Surgical Matrix, 3cc (CG-03AP);Accelagen Plus Surgical Matrix, 5cc (CG-05AP);Accelagen Plus Surgical Strip, 125x25x2mm (CG-125X25AP);Accelagen Plus Surgical Strip, 250x25x2mm (CG-250X25AP)
Specialty
Unknown
Country
United States
Location
Berkeley, CA
Clearance type
Traditional
510(k) number
K260711
Submitted
2026-03-05
What this signal means

A clearance starts commercialisation: distribution, reimbursement, software and sales hires.

  1. 268 added in the 30 days to 9 Nov 2026.
  2. Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS

Find the decision makers at Berkeley Advanced Biomaterials

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for Berkeley Advanced Biomaterials in our registers.

More in Unknown

FDA 510(k) Clearances

See all

Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.